HHS · Notice · Rel 100 (Federal Register (major agencies))
Advisory Committee; Peripheral and Central Nervous System Drugs Advisory Committee; Termination and Reestablishment
Other · Health / life sciences · general, public-health, fda-guidance
Source summary
The Food and Drug Administration (FDA) is announcing the termination and reestablishment of the Peripheral and Central Nervous System Drugs Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Peripheral and Central Nervous System Drugs Advisory Committee was terminated on June 4, 2026, because its charter was not renewed on or before that expiration date. The Commissioner has determined that it is in the public interest to reestablish the Peripheral and Central Nervous System Drugs Advisory Committee for 2 years from the date it is reestablished.
Analyst note
HHS published an official item relevant to other. Use the source link to verify scope before advising clients.
Public reaction (Reddit)
Insufficient public reaction to score sentiment.